Mounjaro (tirzepatide)

**Product type:** Human Prescription Drug

**Active ingredient:** TIRZEPATIDE

**Strength:** 12.5 mg/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Eli Lilly and Company

**Marketing category:** NDA (NDA215866)

**Pharmacologic class:** G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]